After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Zentalis Pharmaceuticals Inc is $153.94M. A total of 3.28 million shares were traded on the day, compared to an average of 1.84M shares.
In the most recent transaction, Vultaggio Vincent sold 2,615 shares of ZNTL for 1.71 per share on Feb 03 ’25. After the transaction, the PAO and Interim PFO now owns 189,826 company shares. In a previous transaction on Feb 03 ’25, Lackner Mark sold 14,368 shares at 1.71 per share. ZNTL shares that Chief Scientific Officer owns now total 512,856.
Among the insiders who sold shares, Paul Andrea disposed of 13,230 shares on Feb 03 ’25 at a per-share price of $1.71. This resulted in the Chief Legal Officer holding 1,070,784 shares of ZNTL after the transaction. In another insider transaction, Skvarka Jan bought 60,000 shares at $1.72 per share on Jan 31 ’25. Company shares held by the Director now total 149,551.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ZNTL has a high of $18.07 and a low of $1.61.
As of this writing, ZNTL has an earnings estimate of -$0.68 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.47 per share and a lower estimate of -$0.99.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ZNTL’s latest balance sheet shows that the firm has $339.89M in Cash & Short Term Investments as of fiscal 2021. There were $44.46M in debt and $43.94M in liabilities at the time. Its Book Value Per Share was $4.98, while its Total Shareholder’s Equity was $364.48M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZNTL is Buy with a score of 3.91.
